Family history of breast cancer: how important is it?
This issue contains two manuscripts which discuss the relevance of family history to risk of breast cancer.' 2 In both these studies, a series of index cases with breast cancer have been interviewed and their family history of breast cancer examined. The first study involves the families of cases attending the Royal Free Hospital and University College, London, while the second was conducted using families identified by the Icelandic Cancer Registry. While many of the risks estimated here are similar to those presented in a number of previous studies, these two manuscripts should not be read as a repeat of these studies. Instead both manuscripts help put the previous epidemiological results into new perspectives.
The general conclusions that relatives of breast cancer cases are at increased risk, the extent of which is dependent upon the age of onset of the index case, higher risks being associated with early onset, have been made by a number of authors.39 Increased risks are also associated with bilaterality of the index case.
Formally, the risks calculated in these two studies are quite similar both to each other and those previously published. For index cases over the age of 55 the increased risk to first degree relatives is estimated to be 1 shown to result from a mutation in the p53 gene, which is located on chromosome 17p. '2 There are important contributions to our thinking of a family history of breast cancer contained in these manuscripts that distinguish them from the large number of studies mentioned above. In the paper by Houlston et al,' the authors write from the perspective of geneticists with vast experience of clinics for families with cancer. Although their study is not based per se on those cases seen in such a clinic, the presentation is in terms of the risk for cancer in the next years or the lifetime risk of breast cancer, exactly the figures required in talking to a patient with a family history of breast cancer and discussing risks or the necessity of screening. Houlston et al' estimate that inherited susceptibility to breast cancer may explain almost 40% of cases diagnosed before the age of 30 to 8% by the age of 45 so that even though this susceptibility may only explain 4 to 5% of all breast cancer, it is a common cause of early onset breast cancer. This prediction can now be tested using the DNA marker close to the 17q locus identified by Hall et al.'0 A similar calculation for the Cancer and Steroid Hormone study conducted in the USA gives very similar estimates for the importance of inherited susceptibility. 13 The manuscript by Tulinius et al,2 by contrast, is basic epidemiological research but with the important advantage of being able to examine the family history of breast cancer in terms of extended pedigrees and risks to second and third degree relatives. Their observation of increased risk for these more distant relatives is consistent with the importance of genetic susceptibility to risk. Indeed, following Risch,'4 if breast cancer resulted from susceptibility at a single locus, and if the risk to first degree relatives were indeed 2.26, then this would translate into a risk to second degree relatives of 1.63, which is similar to the estimate of 1.43 given in the manuscript.
These are exciting times for those interested in genetics and cancer susceptibility, especially to breast cancer. These two manuscripts help us to recognise the importance of family history and to realise that, in some cases, family history is exceptionally strong. Even 
